B2C2, a global over-the-counter liquidity provider, has secured a MiCA license in Luxembourg, allowing it to offer spot OTC trading services across the European Union and three European Economic Area countries. The license, granted by Luxembourg’s financial regulator, enables the firm to use MiCA’s passporting regime for cross-border digital asset liquidity under a single regulatory framework.
The company announced on Friday that this approval marks B2C2 as the first global OTC liquidity provider to receive a Crypto Asset Service Provider (CASP) license under MiCA. B2C2 had previously registered as a virtual asset service provider in Luxembourg in 2024, which laid the groundwork for this broader authorization.
What the MiCA License Means for B2C2
With this license, B2C2 can now extend its services to clients across all 27 EU member states, plus Norway, Iceland, and Liechtenstein, without needing separate approvals in each country. The firm says this will streamline operations for institutional clients seeking compliant access to digital asset markets. B2C2 CEO Thomas Restout said the authorization highlights the company’s commitment to regulatory standards and governance, though it also reflects the growing importance of MiCA as a harmonized rulebook for crypto in Europe.
The timing is notable because the full application of MiCA since December 2024 has pushed many crypto firms to seek licenses before a key transition deadline in July 2026. B2C2’s move suggests that even established OTC players see value in proactive compliance, even if the framework still has some unresolved questions around stablecoins and decentralized finance.
Growing List of MiCA License Holders
B2C2 joins a small but growing list of companies operating under MiCA licenses in Europe. Coinbase secured a similar license in Luxembourg earlier this year, and Kraken obtained one in Ireland. This trend indicates that MiCA is becoming the de facto standard for crypto firms wanting to operate across borders in the EU, though some critics argue the framework’s complexity could deter smaller players.
For B2C2, the license is a logical step after its earlier registration in Luxembourg. The firm likely hopes that being first among OTC providers will give it a competitive edge, though it remains to be seen how regulators will enforce the rules in practice. The company did not disclose specific expansion plans but said the license supports its long-term strategy to serve institutional clients in Europe.
